BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McKillop IH, Moran DM, Jin X, Koniaris LG. Molecular pathogenesis of hepatocellular carcinoma. J Surg Res. 2006;136:125-135. [PMID: 17023002 DOI: 10.1016/j.jss.2006.04.013] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Pedroso FE, Koniaris LG. Shunting: A Better Way to Prevent Variceal Bleeding. Journal of Surgical Research 2011;167:e1-3. [DOI: 10.1016/j.jss.2010.12.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Vedantham K, Swet JH, Mckillop IH, El-ghannam A. Evaluation of a bioresorbable drug delivery system for the treatment of hepatocellular carcinoma. J Biomed Mater Res 2012;100A:432-40. [DOI: 10.1002/jbm.a.33228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
3 Avila MA, Lu KP. Hepatitis B Virus X Protein and Pin1 in Liver Cancer: “Les Liaisons Dangereuses”. Gastroenterology 2007;132:1180-3. [DOI: 10.1053/j.gastro.2007.01.061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
4 Sokolov E, Eheim AL, Ahrens WA, Walling TL, Swet JH, McMillan MT, Simo KA, Thompson KJ, Sindram D, McKillop IH. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma. J Surg Res 2013;180:104-13. [PMID: 23182454 DOI: 10.1016/j.jss.2012.10.054] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
5 Padma S, Smeltz AM, Banks PM, Iannitti DA, McKillop IH. Altered aquaporin 9 expression and localization in human hepatocellular carcinoma. HPB (Oxford). 2009;11:66-74. [PMID: 19590626 DOI: 10.1111/j.1477-2574.2008.00014.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
6 Milgrom DP, Maluccio MA, Koniaris LG. Management of Hepatocellular Carcinoma (HCC). Curr Surg Rep 2016;4. [DOI: 10.1007/s40137-016-0143-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Yang L, Xu M, Cui CB, Wei PH, Wu SZ, Cen ZJ, Meng XX, Huang QG, Xie ZC. Diagnostic and prognostic values of the mRNA expression of excision repair cross-complementation enzymes in hepatitis B virus-related hepatocellular carcinoma. Cancer Manag Res 2018;10:5313-28. [PMID: 30464628 DOI: 10.2147/CMAR.S179043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 El-Agamy DS. Comparative effects of curcumin and resveratrol on aflatoxin B(1)-induced liver injury in rats. Arch Toxicol. 2010;84:389-396. [PMID: 20112103 DOI: 10.1007/s00204-010-0511-2] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
9 Fathy AH, Bashandy MA, Bashandy SA, Mansour AM, Elsadek B. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model. Can J Physiol Pharmacol 2017;95:1462-72. [DOI: 10.1139/cjpp-2017-0413] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
10 Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 2010;291:120-9. [PMID: 19900758 DOI: 10.1016/j.canlet.2009.10.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
11 Monga SP. Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol. 2011;43:1021-1029. [PMID: 19747566 DOI: 10.1016/j.biocel.2009.09.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 7.7] [Reference Citation Analysis]
12 Ren Y, Qiu L, Lü F, Ru X, Li S, Xiang Y, Yu S, Zhang Y. TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells. Sci Rep 2016;6:23775. [PMID: 27065079 DOI: 10.1038/srep23775] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
13 Koniaris LG, Levi DM, Pedroso FE, Franceschi D, Tzakis AG, Santamaria-Barria JA, Tang J, Anderson M, Misra S, Solomon NL. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg. 2011;254:527-537; discussion 537-538. [PMID: 21865950 DOI: 10.1097/sla.0b013e3182ca66f] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Su WH, Jou YS, Zhang JH, Ho CM, Tai DI. Mutations in NOTCH1 and nucleotide excision repair genes are correlated with prognosis of hepatitis B virus-associated hepatocellular carcinoma. J Cancer 2018;9:2678-86. [PMID: 30087708 DOI: 10.7150/jca.25438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Yang SF, Chang CW, Wei RJ, Shiue YL, Wang SN, Yeh YT. Involvement of DNA damage response pathways in hepatocellular carcinoma. Biomed Res Int 2014;2014:153867. [PMID: 24877058 DOI: 10.1155/2014/153867] [Cited by in Crossref: 21] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
16 Wang Q, Koniaris LG, Milgrom DP, Patel A, Hu M, Cui E, Deng Y, Akisik F. CT and MRI imaging and interpretation of hepatic arterioportal shunts. Transl Gastroenterol Hepatol 2019;4:34. [PMID: 31231701 DOI: 10.21037/tgh.2019.05.05] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
17 Thompson KJ, Swan RZ, Iannitti DA, McKillop IH, Sindram D. Diet-induced obesity and ethanol impair progression of hepatocellular carcinoma in a mouse mesenteric vein injection model. Surg Endosc 2013;27:246-55. [PMID: 22806512 DOI: 10.1007/s00464-012-2429-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
18 Brandon-Warner E, Walling TL, Schrum LW, McKillop IH. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res. 2012;36:641-653. [PMID: 22017344 DOI: 10.1111/j.1530-0277.2011.01660.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
19 Mak LY, Cruz-Ramón V, Chinchilla-López P, Torres HA, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK, Bailey HH, Méndez-Sánchez N, Yuen MF, Hwang JP. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. Am Soc Clin Oncol Educ Book 2018;38:262-79. [PMID: 30231359 DOI: 10.1200/EDBK_200939] [Cited by in Crossref: 62] [Cited by in F6Publishing: 43] [Article Influence: 15.5] [Reference Citation Analysis]
20 Karakousis ND, Papatheodoridi A, Chatzigeorgiou A, Papatheodoridis G. Cellular senescence and hepatitis B-related hepatocellular carcinoma: An intriguing link. Liver Int 2020;40:2917-27. [PMID: 32890439 DOI: 10.1111/liv.14659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
21 Spano D, Cimmino F, Capasso M, D’angelo F, Zambrano N, Terracciano L, Iolascon A. Changes of the Hepatic Proteome in Hepatitis B-Infected Mouse Model at Early Stages of Fibrosis. J Proteome Res 2008;7:2642-53. [DOI: 10.1021/pr7006522] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
22 Brandon-Warner E, Benbow JH, Swet JH, Feilen NA, Culberson CR, McKillop IH, deLemos AS, Russo MW, Schrum LW. Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis. Hum Gene Ther 2018;29:674-86. [PMID: 29281894 DOI: 10.1089/hum.2017.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Glauert HP, Calfee-Mason K, Stemm DN, Tharappel JC, Spear BT. Dietary antioxidants in the prevention of hepatocarcinogenesis: a review. Mol Nutr Food Res. 2010;54:875-896. [PMID: 20512789 DOI: 10.1002/mnfr.200900482] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
24 Dawson SP. Hepatocellular carcinoma and the ubiquitin-proteasome system. Biochim Biophys Acta 2008;1782:775-84. [PMID: 18778769 DOI: 10.1016/j.bbadis.2008.08.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
25 Gallicchio R, Nardelli A, Mainenti P, Nappi A, Capacchione D, Simeon V, Sirignano C, Abbruzzi F, Barbato F, Landriscina M. Therapeutic Strategies in HCC: Radiation Modalities. Biomed Res Int. 2016;2016:1295329. [PMID: 27563661 DOI: 10.1155/2016/1295329] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
26 Yu JQ, Yin Y, Lei JC, Zhang XQ, Chen W, Ding CL, Wu S, He XY, Liu YW, Zou GL. Activation of apoptosis by ethyl acetate fraction of ethanol extract of Dianthus superbus in HepG2 cell line. Cancer Epidemiol 2012;36:e40-5. [PMID: 21959229 DOI: 10.1016/j.canep.2011.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wang SH, Chen LM, Yang WK, Lee JD. Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization. World J Gastroenterol 2011; 17(42): 4675-4681 [PMID: 22180709 DOI: 10.3748/wjg.v17.i42.4675] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
28 Kays JK, Milgrom DP, Koniaris LG. Resection or transplantation for hepatocellular carcinoma: is the decision clear for patients beyond Milan criteria? Hepatobiliary Surg Nutr 2017;6:284-6. [PMID: 28848756 DOI: 10.21037/hbsn.2017.04.03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Dipasco PJ, Misra S, Koniaris LG. Conformational technique for non-anatomic resection of liver lesions. J Gastrointest Surg 2012;16:1972-5. [PMID: 22782246 DOI: 10.1007/s11605-012-1957-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K, Salto-Tellez M. Molecular pathology of RUNX3 in human carcinogenesis. Biochim Biophys Acta. 2009;1796:315-331. [PMID: 19682550 DOI: 10.1016/j.bbcan.2009.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 58] [Article Influence: 1.2] [Reference Citation Analysis]
31 Koniaris LG, Levi DM, Pedroso FE, Franceschi D, Tzakis AG, Santamaria-Barria JA, Tang J, Anderson M, Misra S, Solomon NL, Jin X, DiPasco PJ, Byrne MM, Zimmers TA. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg 2011;254:527-37; discussion 537-8. [PMID: 21865950 DOI: 10.1097/SLA.0b013e31822ca66f] [Cited by in Crossref: 77] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
32 Brandon-Warner E, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Lett 2012;326:88-95. [PMID: 22863537 DOI: 10.1016/j.canlet.2012.07.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
33 Zheng J, Zhao M, Li J, Lou G, Yuan Y, Bu S, Xi Y. Obesity-associated digestive cancers: A review of mechanisms and interventions. Tumour Biol 2017;39:1010428317695020. [PMID: 28351315 DOI: 10.1177/1010428317695020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
34 Brandon-Warner E, Schrum LW, Schmidt CM, McKillop IH. Rodent models of alcoholic liver disease: of mice and men. Alcohol. 2012;46:715-725. [PMID: 22960051 DOI: 10.1016/j.alcohol.2012.08.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 7.1] [Reference Citation Analysis]
35 Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol. 2011;11:2083-2088. [PMID: 22019522 DOI: 10.1016/j.meegid.2011.09.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
36 Fang F, Yang L, Tao Y, Qin W. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Cancer 2012;118:134-46. [PMID: 21713761 DOI: 10.1002/cncr.26251] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
37 Zeng G, Apte U, Cieply B, Singh S, Monga SP. siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 2007;9:951-9. [PMID: 18030363 DOI: 10.1593/neo.07469] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 5.5] [Reference Citation Analysis]
38 Alm-Eldeen AA, Mona MH, Shati AA, El-Mekkawy HI. Synergistic effect of black tea and curcumin in improving the hepatotoxicity induced by aflatoxin B1 in rats. Toxicol Ind Health 2015;31:1269-80. [PMID: 23796760 DOI: 10.1177/0748233713491807] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
39 Chen CL, Chang WC, Yi CH, Hung JS, Liu TT, Lei WY, Hsu CS. Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: A 5-year population-based cohort study. J Formos Med Assoc 2019;118:628-35. [PMID: 30122312 DOI: 10.1016/j.jfma.2018.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
40 Campaner R. Understanding mechanisms in the health sciences. Theor Med Bioeth 2011;32:5-17. [PMID: 21132564 DOI: 10.1007/s11017-010-9166-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
41 Ojha R, Nandani R, Chatterjee N, Prajapati VK. Emerging Role of Circular RNAs as Potential Biomarkers for the Diagnosis of Human Diseases. Adv Exp Med Biol 2018;1087:141-57. [PMID: 30259364 DOI: 10.1007/978-981-13-1426-1_12] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
42 Zimmers TA, Jin X, Gutierrez JC, Acosta C, McKillop IH, Pierce RH, Koniaris LG. Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol 2008;134:753-9. [PMID: 18210153 DOI: 10.1007/s00432-007-0336-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
43 Monga SP. Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol. 2011;43:1021-1029. [PMID: 19747566 DOI: 10.1016/j.biocel.2009.09.001s1357-2725(09)00244-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Jung SW, Park NH, Shin JW, Park BR, Kim CJ, Lee JE, Shin ES, Kim JA, Chung YH. Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival. J Hepatol. 2012;57:621-627. [PMID: 22659345 DOI: 10.1016/j.jhep.2012.04.039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
45 Arbuthnot P, Thompson LJ. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1670-1681 [PMID: 18350598 DOI: 10.3748/wjg.14.1670] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
46 Wu J, Shen SL, Chen B, Nie J, Peng BG. Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma. PLoS One. 2014;9:e95849. [PMID: 24770339 DOI: 10.1371/journal.pone.0095849] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
47 Jin X, Zhang Z, Beer-stolz D, Zimmers TA, Koniaris LG. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology 2007;46:802-12. [DOI: 10.1002/hep.21728] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
48 Mohajeri M, Behnam B, Cicero AFG, Sahebkar A. Protective effects of curcumin against aflatoxicosis: A comprehensive review. J Cell Physiol 2018;233:3552-77. [PMID: 29034472 DOI: 10.1002/jcp.26212] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
49 Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 2009;49:821-31. [PMID: 19101982 DOI: 10.1002/hep.22695] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 8.4] [Reference Citation Analysis]
50 Abu-Duhier F, Pooranachandran V, McDonagh AJG, Messenger AG, Cooper-Knock J, Bakri Y, Heath PR, Tazi-Ahnini R. Whole Genome Sequencing in an Acrodermatitis Enteropathica Family from the Middle East. Dermatol Res Pract 2018;2018:1284568. [PMID: 30174688 DOI: 10.1155/2018/1284568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Thompson KJ, Swan RZ, Walling TL, Iannitti DA, Mckillop IH, Sindram D. Obesity, but not ethanol, promotes tumor incidence and progression in a mouse model of hepatocellular carcinoma in vivo. Surg Endosc 2013;27:2782-91. [DOI: 10.1007/s00464-013-2808-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
52 Pogribny IP, Rusyn I, Beland FA. Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol Mutagen 2008;49:9-15. [PMID: 17879298 DOI: 10.1002/em.20342] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
53 Deng Y, Xie M, Xie L, Wang J, Li T, He Y, Li R, Li S, Qin X. Association between polymorphism of the interleukin-13 gene and susceptibility to hepatocellular carcinoma in the Chinese population. PLoS One. 2015;10:e0116682. [PMID: 25658755 DOI: 10.1371/journal.pone.0116682] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
54 Velázquez-Miranda E, Díaz-Muñoz M, Vázquez-Cuevas FG. Purinergic signaling in hepatic disease. Purinergic Signal 2019;15:477-89. [PMID: 31576486 DOI: 10.1007/s11302-019-09680-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
55 Kiran M, Saxena R, Chawla YK, Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem. 2009;327:7-13. [PMID: 19194663 DOI: 10.1007/s11010-009-0035-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
56 Santonocito C, Scapaticci M, Nedovic B, Annicchiarico EB, Guarino D, Leoncini E, Boccia S, Gasbarrini A, Capoluongo E. XRCC1 Arg399Gln Gene Polymorphism and Hepatocellular Carcinoma Risk in the Italian Population. Int J Biol Markers 2017;32:190-4. [DOI: 10.5301/jbm.5000241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
57 Tang J, Xie Y, Xu X, Yin Y, Jiang R, Deng L, Tan Z, Gangarapu V, Tang J, Sun B. Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma. Cell Death Dis. 2017;8:e2675. [PMID: 28300839 DOI: 10.1038/cddis.2017.81] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
58 Thompson KJ, Lau KN, Johnson S, Martinie JB, Iannitti DA, McKillop IH, Sindram D. Leptin inhibits hepatocellular carcinoma proliferation via p38-MAPK-dependent signalling. HPB (Oxford). 2011;13:225-233. [PMID: 21418127 DOI: 10.1111/j.1477-2574.2010.00259.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
59 Salvi A, Abeni E, Portolani N, Barlati S, De Petro G. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC. Int J Oncol. 2013;42:391-402. [PMID: 23229173 DOI: 10.3892/ijo.2012.1716] [Cited by in Crossref: 33] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
60 Liang TW, Feliciano DV, Koniaris LG. A surgery trainee's guide to writing a manuscript. Am J Surg 2017;214:558-63. [PMID: 28031145 DOI: 10.1016/j.amjsurg.2016.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
61 Akkiz H, Sümbül AT, Bayram S, Bekar A, Akgöllü E. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer Epidemiol 2010;34:448-52. [PMID: 20447891 DOI: 10.1016/j.canep.2010.04.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
62 Moran DM, Mattocks MA, Cahill PA, Koniaris LG, McKillop IH. Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J Surg Res 2008;147:23-33. [PMID: 17574577 DOI: 10.1016/j.jss.2007.04.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
63 El-Bahr SM. Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1. Phytother Res 2015;29:134-40. [PMID: 25639897 DOI: 10.1002/ptr.5239] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 8.4] [Reference Citation Analysis]
64 Li W, Tsao H, Chen Y, Cheng S, Hsu Y. A study on the photodynamic properties of chlorophyll derivatives using human hepatocellular carcinoma cells. Photochem Photobiol Sci 2007;6:1341. [DOI: 10.1039/b704539e] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
65 Metodieva S. Molecular Pathogenesis of Hepatocellular Carcinoma. Balkan Journal of Medical Genetics 2007;10:15-22. [DOI: 10.2478/v10034-008-0002-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Hayes CN, Zhang P, Zhang Y, Chayama K. Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection. Viruses. 2018;10. [PMID: 30274202 DOI: 10.3390/v10100531] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
67 Bose S, Tripathi DM, Sukriti, Sakhuja P, Kazim SN, Sarin SK. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene 2013;519:231-7. [PMID: 23454624 DOI: 10.1016/j.gene.2013.02.025] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
68 Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol 2015; 7(26): 2648-2663 [PMID: 26609342 DOI: 10.4254/wjh.v7.i26.2648] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 16.6] [Reference Citation Analysis]